Browse 24807 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
February 18th, 2021 |
Coccidioidomycosis Collaborative Research Centers (U19 Clinical Trial Not Allowed) |
National Institutes of Health |
September 5th, 2022 |
Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed) |
National Institutes of Health |
April 12th, 2021 |
Research Grants to Develop or Identify Effective Strategies to Prevent Overdose Involving Illicit Stimulants and Polysubstance Use Involving Stimulants |
Centers for Disease Control and Prevention ERA |
July 16th, 2021 |
Shoulder to Shoulder: Accompanying Ministries of Health in Central America in Strengthening Local and Global Health Security |
Centers for Disease Control CGH |
February 8th, 2021 |
A Multidisciplinary Approach to Study Vaccine-elicited Immunity and Efficacy against Malaria (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
March 22nd, 2021 |
Research Grants for Preventing Violence and Violence Related Injury (R01) |
Centers for Disease Control and Prevention ERA |
April 5th, 2021 |
Rigorous Evaluation of Policies for their Impacts on the Primary Prevention of Multiple Forms of Violence |
Centers for Disease Control and Prevention ERA |
February 3rd, 2021 |
MD-PhD Training Program in Alzheimer's Disease and Related Dementias and the Behavioral and Social Sciences (T32 Clinical Trial Not Allowed) |
National Institutes of Health |
December 8th, 2020 |
Cooperative Research Agreements Related to the World Trade Center Health Program (U01) |
Centers for Disease Control and Prevention ERA |
December 10th, 2020 |
Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
July 23rd, 2023 |
Successor-in-Interest (Type 6 Parent Clinical Trial Optional) |
National Institutes of Health |
April 2nd, 2021 |
Building Sustainable Health Systems and Laboratory Services in Cote d'Ivoire under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
January 7th, 2023 |
Multidisciplinary Approaches to HIV-Associated Comorbidities and Prioritizing Intervention Targets (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
October 31st, 2023 |
Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01) |
National Institutes of Health |
February 22nd, 2021 |
Understanding the Role of the M. Tuberculosis Granuloma in Tuberculosis (TB) Disease and Treatment Outcomes (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
December 18th, 2020 |
Monitoring Cause-specific School Absenteeism for Estimating Community-wide Influenza and SARS-CoV-2 Transmission |
Centers for Disease Control and Prevention ERA |
December 16th, 2020 |
State Occupational Safety and HealthSurveillance Program (U60) |
Centers for Disease Control and Prevention ERA |
March 22nd, 2021 |
Human Papillomavirus (HPV) Roundtable: Supporting a National Network of Partners to Promote Cancer Prevention through Human Papillomavirus Vaccination |
Centers for Disease Control NCIRD |
February 4th, 2021 |
Cohort Studies To Improve Our Understanding of Influenza Immunity, Vaccine Response and Effectiveness in Older Adults (65 years and older) (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
March 27th, 2023 |
Health Services Research on Minority Health and Health Disparities (R01- Clinical Trial Optional) |
National Institutes of Health |
|
January 7th, 2024 |
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2021, 2022, and 2023 (P50 Clinical Trial Required) |
National Institutes of Health |
January 8th, 2021 |
Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
January 8th, 2021 |
Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
December 14th, 2021 |
Using Syndemics to Understand HLBS Disease Emergence and Progression in People with HIV (PWH)(R01 Clinical Trial Not Allowed) |
National Institutes of Health |
December 16th, 2020 |
Limited Competition for the Continuation of the Scientific Data Research Center (SDRC) for the NIDDK Gastroparesis Consortium (U24 Clinical Trial Optional) |
National Institutes of Health |
December 16th, 2020 |
Limited Competition for the Continuation of Clinical Centers to Investigate the Pathogenesis, Etiology, and Treatment of Gastroparesis through the NIDDK Gastroparesis Consortium (U01 Clinical Trial Optional) |
National Institutes of Health |
December 9th, 2022 |
BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) |
National Institutes of Health |
February 11th, 2021 |
Understanding Evolutionary Dynamics of Influenza to Inform and Improve Vaccine Strain Selection (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
April 19th, 2021 |
Advancing Sustainable Implementation of Comprehensive HIV/TB Services for Epidemic Control in the Republic of Mozambique under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
April 9th, 2021 |
Strengthen Capacity of South African Government's Department of Health and Implementing Partners to Deliver Quality Differentiated, Advanced Clinical Care (ACC) for Unstable HIV and TB/HIV Patients in the Republic of |
Centers for Disease Control CGH |
July 2nd, 2021 |
Building Resilience Against Climate Effects: Implementing and Evaluating Adaptation Strategies that Protect and Promote Human Health |
Centers for Disease Control NCEH |
September 23rd, 2022 |
Department of Defense HIV/AIDS Prevention Program |
Dept of the Army USAMRAA |
December 18th, 2020 |
US Travelers Health Research, Surveillance, Communication, and Outreach Network |
Centers for Disease Control and Prevention ERA |
December 14th, 2021 |
Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional) |
National Institutes of Health |
January 15th, 2021 |
Pediatric and Reproductive Environmental Health Scholars (PREHS): Strengthening the Pipeline (K12 Clinical Trial Not Allowed) |
National Institutes of Health |
December 21st, 2020 |
Thalassemia Program |
Health Resources and Services Administration |
April 5th, 2021 |
Advancing Comprehensive Community-Based HIV Services to Achieve Epidemic Control in Namibia under the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
April 19th, 2021 |
Sustaining HIV Epidemic Control through Efficient Case Finding and Quality Care and Treatment Services in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
April 19th, 2021 |
Strengthening Systems to Improve HIV Service Delivery and Other Public Health Interventions Through Continuous Quality Improvement, Monitoring and Evaluation, Surveillance, Health Informatics and Laboratory Quality |
Centers for Disease Control CGH |
April 19th, 2021 |
Strengthening Capacity within the Zambian Ministry of Health for Health Information Systems Sustainability in Support of a Data Driven National HIV/AIDS Response under the President's Emergency Plan for AIDS Relief |
Centers for Disease Control CGH |